Records containing: Neuroblastoma (NB)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-29Chemoimmunotherapy Combined With Autologous NK Cell Therapy for the Treatment of Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
-
CLINICAL_TRIALS study record update · 2026-01-06A Phase II Trial of Chidamide Combined With Dinutuximab Beta, Irinotecan, and Temozolomide for Refractory or Relapsed Neuroblastoma in Children
-
CLINICAL_TRIALS study record update · 2025-11-03Fecal Microbiota Transplant for Neuroblastoma in a Single Patient
-
CLINICAL_TRIALS study record update · 2025-07-21Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
-
CLINICAL_TRIALS study record update · 2025-07-02Phase II Study of Hu3F8, Irinotecan/Temozolomide and Sargramostim (HITS) Chemoimmunotherapy for High-Risk Neuroblastoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-15Bone Marrow Cytology-based Artificial Intelligence Model for Detection and Prognosis of Neuroblastoma
-
CLINICAL_TRIALS study record update · 2025-04-09Evaluation of Safety and Efficacy Evaluation Post Intravenous Infusion of Activated NK Cells in Recurrent and Refractory High-risk Neuroblastoma Patients
-
CLINICAL_TRIALS study record update · 2025-03-13Using EQ-5D-Y to Measure the Health of Patients for Multiple Paediatric Health Conditions: a Project to Validate the Self-complete, Interviewer-administered and Proxy Administered Versions of EQ-5D-Y-3L and EQ-5D-Y-5L in China
-
CLINICAL_TRIALS study record update · 2025-02-26Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.